Back to Anglo Platinum  | Downloads  | Glossary  | Contact
	Home          Profile & mission          Key features          Chairman‘s statement          The board & executive          CEOs‘ review          Finance review       +   Market review       +   Operations review          Ore reserves & mineral resources review          Projects review       +   Company statistics            Financial statements Approval of the Annual Financial Statements Declaration by the Company Secretary Auditor‘s Report Directors‘ Report Remuneration Report Audit Committee Report Principal accounting policies Consolidated Income Statement Segmental Information Consolidated Balance Sheet Consolidated Cash Flow Statement Group Statement of Recognised Income and Expense United States Dollar Equivalent Consolidated Income Statement United States Dollar Equivalent Consolidated Balance Sheet United States Dollar Equivalent Consolidated Cash Flow Statement Notes to the Consolidated Financial Statements Annexures Appendix 1       +   Directorate & management       +   Shareholders‘ information	Financial statements  |  Notes to the Consolidated Financial Statements   print page   email page   PDF 639KB Explore Notes ---------------------------------------------------------------------------------------------- 1. Gross sales revenue ---------------------------------------------------------------------------------------------- 2. Exchange rates to the South African rand ---------------------------------------------------------------------------------------------- 3. Cash operating costs ---------------------------------------------------------------------------------------------- 4. Depreciation of operating assets ---------------------------------------------------------------------------------------------- 5. Other costs ---------------------------------------------------------------------------------------------- 6. Other net expenditure ---------------------------------------------------------------------------------------------- 7. Interest expensed and received ---------------------------------------------------------------------------------------------- 8. Profit before taxation ---------------------------------------------------------------------------------------------- 9. Taxation ---------------------------------------------------------------------------------------------- 10. Earnings per ordinary share ---------------------------------------------------------------------------------------------- 11. Reconciliation between net profit       and headline earnings ---------------------------------------------------------------------------------------------- 12. Ordinary and preference dividends ---------------------------------------------------------------------------------------------- 13. Property, plant and equipment ---------------------------------------------------------------------------------------------- 14. Capital work-in-progress ---------------------------------------------------------------------------------------------- 15. Exploration and evaluation ---------------------------------------------------------------------------------------------- 16. Investment in associates ---------------------------------------------------------------------------------------------- 17. Joint ventures ---------------------------------------------------------------------------------------------- 18. Investments held by environmental trusts ---------------------------------------------------------------------------------------------- 19. Other financial assets ---------------------------------------------------------------------------------------------- 20. Other non-current assets ---------------------------------------------------------------------------------------------- 21. Inventories ---------------------------------------------------------------------------------------------- 22. Accounts receivable ---------------------------------------------------------------------------------------------- 23. Other assets ---------------------------------------------------------------------------------------------- 24. Derivative financial assets ---------------------------------------------------------------------------------------------- 25. Cash and cash equivalents ---------------------------------------------------------------------------------------------- 26. Assets held for sale ---------------------------------------------------------------------------------------------- 27. Combined statement of movement in       shareholders’ funds and       movement in reserves ---------------------------------------------------------------------------------------------- 28. Share capital ---------------------------------------------------------------------------------------------- 29. Deferred taxation ---------------------------------------------------------------------------------------------- 30. Environmental obligations ---------------------------------------------------------------------------------------------- 31. Employee benefits ---------------------------------------------------------------------------------------------- 32. Obligations due under finance leases ---------------------------------------------------------------------------------------------- 33. Interest-bearing borrowings ---------------------------------------------------------------------------------------------- 34. Accounts payable ---------------------------------------------------------------------------------------------- 35. Other liabilities ---------------------------------------------------------------------------------------------- 36. Related party transactions ---------------------------------------------------------------------------------------------- 37. Reconciliation of profit before       taxation to cash from operations ---------------------------------------------------------------------------------------------- 38. Taxation paid ---------------------------------------------------------------------------------------------- 39. Purchase of property, plant and equipment ---------------------------------------------------------------------------------------------- 40. Commitments ---------------------------------------------------------------------------------------------- 41. Contingent liabilities ---------------------------------------------------------------------------------------------- 42. Change in accounting estimate ---------------------------------------------------------------------------------------------- 43. Financial instruments ---------------------------------------------------------------------------------------------- 44. Analysis of shareholders ---------------------------------------------------------------------------------------------- 45. Revision of conversion price applicable       to convertible preference shares ---------------------------------------------------------------------------------------------- 46. Comparative figures ---------------------------------------------------------------------------------------------- 47. Post-balance events ----------------------------------------------------------------------------------------------
		Notes to the Consolidated Financial Statements 2007 Rm 2006 Rm 1. Gross sales revenue Sales revenue emanated from the following principal regions: Precious metals 41,490   35,324 Asia 16,499   14,888 Europe 14,426   10,720 Africa 7,232   6,798 North America 3,333   2,918 Base metals 5,278   3,960 Africa 4,783   3,533 Rest of the world 495   427 Other Africa 193   72     46,961   39,356 Gross sales revenue by metal: Platinum 23,412   21,871 Palladium 3,858   3,347 Rhodium 11,325   8,576 Nickel 4,716   3,462 Other 3,650   2,100   Gross sales revenue 46,961   39,356   Gross sales revenue by metal – (%)
		Page up
		Page  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75     Previous page  |  Financial statements 26/75
		Disclaimer